DBMR NEWS

 " Global Pharmacogenetics Testing in Psychiatry/Depression Market  - Overview, Size, Share, Industry Trends and Opportunities Global Pharmacogenetics Testing in Psychiatry/Depression Market, By Type (Anxiety, Depression, Mood Disorders, Bipolar Disorders, Eating Disorders, and Psychotic Disorders), Product (Consumables, Instruments, and Software and Services), Test Type (Whole Genome Sequencing and Chromosomal Array Based Tests), Gene Type (CYP2C19, CYP2C9 and VKORC1, CYP2D6, HLA-B, HTR2A/C, HLA-A, CYP3A4, SLC6A4, MTHFR, COMT, and Others), Patient Type (Adult, Geriatric, and Child), End User (Hospital and Clinics, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distribution, Hospital Pharmacy, and Others) - Industry Trends and Forecast to 2031. Data Bridge Market Research analyzes that the global pharmacogenetics testing in psychiatry/depression market is expected to reach USD 2.66 billion by 2031 from ...

 " Global Pharmacogenetics Testing in Psychiatry/Depression Market  – Industry Trends and Forecast to 2031 Global Pharmacogenetics Testing in Psychiatry/Depression Market, By Type (Anxiety, Depression, Mood Disorders, Bipolar Disorders, Eating Disorders, and Psychotic Disorders), Product (Consumables, Instruments, and Software and Services), Test Type (Whole Genome Sequencing and Chromosomal Array Based Tests), Gene Type (CYP2C19, CYP2C9 and VKORC1, CYP2D6, HLA-B, HTR2A/C, HLA-A, CYP3A4, SLC6A4, MTHFR, COMT, and Others), Patient Type (Adult, Geriatric, and Child), End User (Hospital and Clinics, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distribution, Hospital Pharmacy, and Others) - Industry Trends and Forecast to 2031. Data Bridge Market Research analyzes that the global pharmacogenetics testing in psychiatry/depression market is expected to reach USD 2.66 billion by 2031 from USD 1.22 billion in ...